Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-term Data
07:30am - 03:45pm EDT - March 31, 2023




Author(s):
  • Dr. Abdenour Nabid, MD, FCRP(C), Associate professor Faculty of Medicine, University of Sherbrooke, Québec, Canada, CIUSSS de l'Estrie CHUS: Centre Integre Universitaire de Sante et de Services Sociaux de l'Estrie Centre Hospitalier Universitaire de Sherbrooke du Quebec

Tags: Clinical Oncology

Display Label Action
AC23P20 - Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-term Data Download MP3
020-General Poster Session Download Handout